Wordt geladen...
Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer
PURPOSE/OBJECTIVES: Primary endpoint analysis of RTOG 0247 demonstrated preoperative RT with capecitabine plus oxaliplatin achieved a pCR pre-specified threshold (21%) to merit further study, whereas the RT with capecitabine plus irinotecan arm did not (10%). Secondary efficacy endpoints are reporte...
Bewaard in:
Gepubliceerd in: | Int J Radiat Oncol Biol Phys |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385459/ https://ncbi.nlm.nih.gov/pubmed/25446610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2014.09.031 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|